Daniel Lee Flynn - Net Worth and Insider Trading

Daniel Lee Flynn Net Worth

The estimated net worth of Daniel Lee Flynn is at least $10 Million dollars as of 2025-05-09. Daniel Lee Flynn is the Chief Scientific Officer of Deciphera Pharmaceuticals Inc and owns about 378,613 shares of Deciphera Pharmaceuticals Inc (DCPH) stock worth over $10 Million. Details can be seen in Daniel Lee Flynn's Latest Holdings Summary section.

Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Daniel Lee Flynn has not made any transactions after 2023-06-16 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.

GuruFocus Premium Membership
30 Years of Financial Data
Unlimited Filters in All-in-One Stock Screener
Earnings Calls & Stock Analysis
Customizable Stock Dashboard
Real-Time Insider Trading Alerts
8,000+ Institutional Investors’ 13F Holdings
Excel & Google Sheets Integration
Quick Customer Support
And Much More...

Transaction Summary of Daniel Lee Flynn

To

Daniel Lee Flynn Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Daniel Lee Flynn owns 1 companies in total, including Deciphera Pharmaceuticals Inc (DCPH) .

Click here to see the complete history of Daniel Lee Flynn’s form 4 insider trades.

Insider Ownership Summary of Daniel Lee Flynn

Ticker Company Transaction Date Type of Owner
DCPH Deciphera Pharmaceuticals Inc 2023-06-16 Chief Scientific Officer

Daniel Lee Flynn Latest Holdings Summary

Daniel Lee Flynn currently owns a total of 1 stock. Daniel Lee Flynn owns 378,613 shares of Deciphera Pharmaceuticals Inc (DCPH) as of June 16, 2023, with a value of $10 Million.

Latest Holdings of Daniel Lee Flynn

Ticker Company Latest Transaction Date Shares Owned Current Price ($) Current Value ($)
DCPH Deciphera Pharmaceuticals Inc 2023-06-16 378,613 25.59 9,688,707

Holding Weightings of Daniel Lee Flynn


Daniel Lee Flynn Form 4 Trading Tracker

According to the SEC Form 4 filings, Daniel Lee Flynn has made a total of 5 transactions in Deciphera Pharmaceuticals Inc (DCPH) over the past 5 years, including 0 buys and 5 sells. The most-recent trade in Deciphera Pharmaceuticals Inc is the sale of 1,655 shares on June 16, 2023, which brought Daniel Lee Flynn around $23,832.

Insider Trading History of Daniel Lee Flynn

No transactions are available. GuruFocus only tracks and displays the purchase and sale of non-derivative security in open market or private transactions from SEC filings with the transaction code of P or S.
Total 0
  • 1
Only the transactions in Open Market or Private Sale at the market prices are included. Other transactions such as conversion of derivative security or exercise of options are not included. Insiders are limited to only officers and/or directors of the company.

Daniel Lee Flynn Trading Performance

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Daniel Lee Flynn Ownership Network

Ownership Network List of Daniel Lee Flynn

No Data

Ownership Network Relation of Daniel Lee Flynn

Insider Network Chart


Daniel Lee Flynn Owned Company Details

What does Deciphera Pharmaceuticals Inc do?

Who are the key executives at Deciphera Pharmaceuticals Inc?

Daniel Lee Flynn is the Chief Scientific Officer of Deciphera Pharmaceuticals Inc. Other key executives at Deciphera Pharmaceuticals Inc include EVP & Chief Medical Officer Matthew L Sherman , Chief Financial Officer Thomas Patrick Kelly , and Chief Commercial Officer Daniel C. Martin .

Deciphera Pharmaceuticals Inc (DCPH) Insider Trades Summary

Over the past 18 months, Daniel Lee Flynn made no insider transaction in Deciphera Pharmaceuticals Inc (DCPH). Other recent insider transactions involving Deciphera Pharmaceuticals Inc (DCPH) include a net sale of 21,152 shares made by Daniel C. Martin , a net sale of 5,227 shares made by Thomas Patrick Kelly , and a net sale of 5,227 shares made by Matthew L Sherman .

In summary, during the past 3 months, insiders sold 0 shares of Deciphera Pharmaceuticals Inc (DCPH) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 65,556 shares of Deciphera Pharmaceuticals Inc (DCPH) were sold and 0 shares were bought by its insiders, resulting in a net sale of 65,556 shares.

Deciphera Pharmaceuticals Inc (DCPH)'s detailed insider trading history can be found in Insider Trading Tracker table.

To

Deciphera Pharmaceuticals Inc Insider Transactions

No Available Data

Daniel Lee Flynn Mailing Address

Above is the net worth, insider trading, and ownership report for Daniel Lee Flynn. Based on the public information released on the U.S. Securities and Exchange Commission (SEC) website, Daniel Lee Flynn's mailing address is: Waltham Ma 02451.